Ryan Specialty (NYSE:RYAN) Hits New 52-Week Low – Should You Sell?

Ryan Specialty Holdings Inc. (NYSE:RYAN) hit a new 52-week low on Tuesday . The company traded as low as $49.93 and last traded at $50.93, with a volume of 273256 shares. The stock had previously closed at $50.75.

Analyst Ratings Changes

Several analysts recently issued reports on the company. TD Cowen reduced their price target on Ryan Specialty from $89.00 to $76.00 and set a “buy” rating for the company in a research note on Wednesday, November 26th. Piper Sandler began coverage on Ryan Specialty in a research note on Thursday, November 20th. They set a “neutral” rating and a $60.00 price objective on the stock. Jefferies Financial Group initiated coverage on Ryan Specialty in a research report on Monday, December 1st. They issued a “hold” rating and a $64.00 price target on the stock. Mizuho began coverage on shares of Ryan Specialty in a research report on Monday, December 15th. They issued a “neutral” rating and a $61.00 target price for the company. Finally, UBS Group decreased their price objective on shares of Ryan Specialty from $80.00 to $75.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $64.81.

Ryan Specialty Stock Down 0.1%

The stock has a market capitalization of $13.38 billion, a price-to-earnings ratio of 110.30, a price-to-earnings-growth ratio of 1.22 and a beta of 0.63. The stock has a 50 day moving average price of $54.52 and a 200 day moving average price of $56.91. The company has a quick ratio of 1.00, a current ratio of 1.00 and a debt-to-equity ratio of 2.72.

Ryan Specialty (NYSE:RYAN) last issued its quarterly earnings results on Thursday, October 30th. The company reported $0.47 earnings per share for the quarter, meeting the consensus estimate of $0.47. The company had revenue of $754.58 million during the quarter, compared to analysts’ expectations of $742.35 million. Ryan Specialty had a return on equity of 47.93% and a net margin of 7.61%.The business’s quarterly revenue was up 24.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.41 earnings per share. As a group, analysts forecast that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current year.

Ryan Specialty Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, November 25th. Shareholders of record on Tuesday, November 11th were paid a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend was Monday, November 10th. Ryan Specialty’s payout ratio is 104.35%.

Insider Buying and Selling at Ryan Specialty

In related news, CEO Timothy William Turner sold 129,570 shares of the company’s stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $53.61, for a total value of $6,946,247.70. Following the sale, the chief executive officer owned 12,553 shares in the company, valued at $672,966.33. This represents a 91.17% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 52.21% of the company’s stock.

Hedge Funds Weigh In On Ryan Specialty

Hedge funds have recently bought and sold shares of the company. Royal Bank of Canada raised its holdings in shares of Ryan Specialty by 10.6% in the first quarter. Royal Bank of Canada now owns 59,639 shares of the company’s stock valued at $4,406,000 after purchasing an additional 5,739 shares during the last quarter. AQR Capital Management LLC grew its position in Ryan Specialty by 25.1% in the 1st quarter. AQR Capital Management LLC now owns 4,972 shares of the company’s stock worth $367,000 after purchasing an additional 998 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in Ryan Specialty by 46.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 376,154 shares of the company’s stock valued at $27,787,000 after buying an additional 119,055 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Ryan Specialty by 11.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 332,823 shares of the company’s stock valued at $24,586,000 after buying an additional 33,667 shares during the last quarter. Finally, Voya Investment Management LLC boosted its stake in shares of Ryan Specialty by 43.5% in the 1st quarter. Voya Investment Management LLC now owns 147,872 shares of the company’s stock worth $10,923,000 after buying an additional 44,843 shares during the last quarter. 84.82% of the stock is owned by hedge funds and other institutional investors.

Ryan Specialty Company Profile

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.